Aaron Moulin

Title: The Innovative Contributions of Aaron Moulin

Introduction

Aaron Moulin is a notable inventor based in Ashland, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. With a total of 2 patents, his work focuses on advancing therapeutic options for various medical conditions.

Latest Patents

Moulin's latest patents include the development of engineered anti-TGF-β antibodies and antigen-binding fragments. These antibodies are designed to bind Transforming Growth Factor-β (TGF-β) with isoform selectivity. Specifically, they may selectively bind human TGF-β1 compared to human TGF-β2 and TGF-β3, or vice versa. The design of these antibodies is supported by co-crystal structures of recombinant Fab fragments and scFv versions bound to TGF-β isoforms.

Career Highlights

Aaron Moulin is currently employed at Genzyme Corporation, a leading biotechnology company. His work at Genzyme has allowed him to focus on innovative solutions in the field of therapeutic antibodies. His contributions have been instrumental in advancing the understanding and application of TGF-β in medical treatments.

Collaborations

Moulin collaborates with talented professionals such as Ronnie Rong Wei and Magali Mathieu. These collaborations enhance the research and development efforts at Genzyme Corporation, fostering an environment of innovation and discovery.

Conclusion

Aaron Moulin's work exemplifies the spirit of innovation in biotechnology. His patents and collaborations contribute to the advancement of medical science, particularly in the area of engineered antibodies. His efforts continue to pave the way for new therapeutic options in healthcare.